North America Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report: Information By Animal Type (Livestock Animal, Companion Animal, Other Animals), By Intervention, By Indication, By End User, and By Country (U.S. And Canada) –

North America Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report: Information By Animal Type (Livestock Animal, Companion Animal, Other Animals), By Intervention, By Indication, By End User, and By Country (U.S. And Canada) – Market Forecast, 2024 - 2032

The North America veterinary clinical trials market size is expected to reach USD 3,841.20 million by 2032, according to a new study by Polaris Market Research. The report “North America Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report, By Animal Type (Livestock Animal, Companion Animal, Other Animals); By Intervention; By Indication; By End Use; By Country; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The development of new drugs, vaccines, and biologics requires rigorous clinical trials to ensure safety and efficacy. Personalized treatments based on genetic profiling of animals boost the need for specialized clinical trials and drive the demand for the North America veterinary clinical trials market.

Also, increasing pet ownership and the humanization of pets have led to higher spending on veterinary healthcare, necessitating advanced treatments and clinical trials. Technological innovations, such as digital health tools and advanced diagnostic imaging, enhance the scope and efficiency of trials.

Regulatory support from bodies like the FDA and Health Canada, coupled with stringent animal welfare regulations, fosters a conducive environment for conducting clinical trials. Collaboration between pharmaceutical companies, research institutions, and veterinary clinics, along with public-private partnerships, accelerates research and development.

The growing prevalence of chronic and infectious diseases in animals drives the need for effective treatments and vaccines. Increased healthcare expenditure and significant investments in veterinary research further bolster the veterinary clinical trials market.

Furthermore, enhanced education and training programs for veterinarians improve the implementation and management of clinical trials. Additionally, growing awareness among pet owners about advanced veterinary care and the economic impact of maintaining livestock health contribute to the demand for veterinary clinical trials market.

North America Veterinary Clinical Trials Market Report Highlights

• In 2023, the companion animal segment accounted for the largest market share due to a rise in pet ownership, driven by changing lifestyles, urbanization, and increased disposable income.
• The pharmaceutical and biopharmaceutical companies segment accounted for the largest market share in 2023 due to their heavy investment in research and development to create innovative veterinary drugs, vaccines, and therapies.
• The U.S. veterinary clinical trials market accounted for the largest market share in 2023 due to its highly developed regulatory framework, particularly through the FDA (Food and Drug Administration), which sets stringent standards for the approval of veterinary products.
• The Nort America key market players include Argenta, Boehringer Ingelheim International GmbH., Charles River Laboratory, Clinvet, Cambridge Technologies, Knoell, IDEXX Laboratories, Inc., Labcorp Drug Development, Merck & Co., Inc., and Vivesto AB.

Polaris Market Research has segmented the North America veterinary clinical trials market report based on animal type, intervention, indication, end-user, and country:

Veterinary Clinical Trials, Animal Type Outlook (Revenue - USD Million, 2019 - 2032)

• Livestock Animal
• Companion Animal
• Other Animals

Veterinary Clinical Trials, Intervention Outlook (Revenue - USD Million, 2019 - 2032)

• Medicines
• Medical Device
• Others

Veterinary Clinical Trials, Indication Outlook (Revenue - USD Million, 2019 - 2032)

• Orthopedics
• Oncology
• Cardiology
• Ophthalmology
• Neurology
• Dermatology
• Internal Medicine
• Other Indication

Veterinary Clinical Trials, End-User Outlook (Revenue - USD Million, 2019 - 2032)

• Academics And Research Centers
• Pharmaceutical And Biopharmaceutical Companies
• Others

Veterinary Clinical Trials, Country Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• US
• Canada